topic

Correction: Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch
Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e001932corr1; DOI: 10.1136/jitc-2020-001932corr1
Correction: Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e001926corr1; DOI: 10.1136/jitc-2020-001926corr1
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
Paul B Chapman, Vetri Sudar Jayaprakasam, Katherine S Panageas, Margaret Callahan, Michael A Postow, Alexander N Shoushtari, Jedd D Wolchok, Allison Betof Warner

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003395; DOI: 10.1136/jitc-2021-003395
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
Geoffrey T. Gibney, Jacob Zaemes, Shelly Shand, Neil J. Shah, David Swoboda, Kellie Gardner, Arash Radfar, Vesna Petronic-Rosic, Michael J. Reilly, Waddah B. Al-Refaie, Suthee Rapisuwon, Michael B. Atkins

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e002955; DOI: 10.1136/jitc-2021-002955
Correction: Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e001895corr1; DOI: 10.1136/jitc-2020-001895corr1
Correction: IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e001647corr1; DOI: 10.1136/jitc-2020-001647corr1
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells
Emiliano Roselli, Justin C Boucher, Gongbo Li, Hiroshi Kotani, Kristen Spitler, Kayla Reid, Estelle V Cervantes, Yannick Bulliard, Nhan Tu, Sae Bom Lee, Bin Yu, Frederick L Locke, Marco L Davila

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003354; DOI: 10.1136/jitc-2021-003354
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
Amy A Lo, Andrew Wallace, Daniel Oreper, Nicolas Lounsbury, Charles Havnar, Ximo Pechuan-Jorge, Thomas D Wu, Richard Bourgon, Ryan Jones, Katrina Krogh, Guang-Yu Yang, Oliver A Zill

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003001; DOI: 10.1136/jitc-2021-003001
Helicobacter pylori infection disturbs the tumor immune microenvironment and is associated with a discrepant prognosis in gastric de novo diffuse large B-cell lymphoma
Yuwei Deng, Wenjia Su, Junwen Zhu, Hongfei Ji, Xiaoping Zhou, Jingshu Geng, Jiayu Zhu, Qingyuan Zhang

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e002947; DOI: 10.1136/jitc-2021-002947
Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors
Chia-Ing Jan, Shi-Wei Huang, Peter Canoll, Jeffrey N Bruce, Yu-Chuan Lin, Chih-Ming Pan, Hsin-Man Lu, Shao-Chih Chiu, Der-Yang Cho

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003050; DOI: 10.1136/jitc-2021-003050

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages